Sanjay Chanda
Fortuna: 166 428 $ al 30/06/2026
Fortuna: 166 428 $ al 30/06/2026
Dr. Sanjay Chanda is a Chief Development Officer at AN2 Therapeutics, Inc. and a Chief Development Officer at Cortene, Inc. Dr. Chanda was previously employed as a Co-Founder by Auration Biotech, Inc., a Senior Vice President-Drug Development by Anacor Pharmaceuticals LLC, and a Chief Development Officer by Tioma Therapeutics, Inc. He received his undergraduate degree from Birla Institute of Technology & Science, a graduate degree from Birla Institute of Technology & Science and a doctorate degree from Northeast Louisiana University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 31/03/2026 | 34.386 ( 0,1 % ) | 166 428 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| AN2 THERAPEUTICS, INC. | Corporate Officer/Principal | 01/11/2019 |
Cortene, Inc.
Cortene, Inc. BiotechnologyHealth Technology Develops therapeutics for treating a broad range of disorders related to the stress response | Corporate Officer/Principal | 01/02/2017 |
| Empresas | Cargo | Fin |
|---|---|---|
Arch Oncology, Inc.
Arch Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company that develops biologic therapies for treatment of patients with tumors and hematologic malignancies | Corporate Officer/Principal | 01/08/2017 |
| ANACOR PHARMACEUTICALS INC | Corporate Officer/Principal | 01/10/2016 |
Auration Biotech, Inc.
Auration Biotech, Inc. BiotechnologyHealth Technology Develops novel therapeutics for treatment of diseases of ear, nose and throat | Fundador | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 7 |
|---|---|
Birla Institute of Technology & Science
Birla Institute of Technology & Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anacor Pharmaceuticals LLC
Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a bio pharmaceutical company | Health Technology |
Northeast Louisiana University
Northeast Louisiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arch Oncology, Inc.
Arch Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company that develops biologic therapies for treatment of patients with tumors and hematologic malignancies | Health Technology |
Auration Biotech, Inc.
Auration Biotech, Inc. BiotechnologyHealth Technology Develops novel therapeutics for treatment of diseases of ear, nose and throat | Health Technology |
AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics | Health Technology |
Cortene, Inc.
Cortene, Inc. BiotechnologyHealth Technology Develops therapeutics for treating a broad range of disorders related to the stress response | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.